CDP Venture Capital

CDP Venture Capital is the state-backed venture manager operated by Cassa Depositi e Prestiti, deploying billions of euros to ensure Italian sovereignty in deep tech and healthcare innovation. Headquartered in Rome with operations across Italy, the firm functions as a strategic instrument of national industrial policy as much as a financial investor, with a mandate to anchor the Italian venture ecosystem and channel public and institutional capital into priority sectors.

The thesis spans digital health, medical devices and medtech, and biotech, with AI focus across those categories. CDP Venture Capital invests where the underlying technology has both commercial promise and strategic relevance to Italian industrial sovereignty, which means healthcare investments often align with national priorities around biotech manufacturing, medical device localization, and digital health infrastructure. The breadth of the firm’s stage coverage reflects its role as an ecosystem anchor rather than a thematic specialist.

The firm writes $5M to $25M checks and is active from Seed through Growth, which is unusually wide stage coverage and reflects its mandate to support Italian companies across their full venture journey. Geographic focus is Italy, with strong preference for Italian-domiciled or Italian-rooted companies, though many portfolio companies operate across European and global markets. Founders building outside Italy will not be a structural fit.

The team operates under the CDP umbrella and benefits from access to Italian institutional networks, public sector relationships, and the broader CDP platform’s expertise in industrial finance. Specific partner names are not provided in the source data, and the LinkedIn listing is unconfirmed, so founders should engage through CDP Venture Capital’s website.

The approach is patient and policy-aligned. CDP Venture Capital is comfortable with long timelines and infrastructure-style investments that pure financial investors might pass on, but founders should expect diligence that examines strategic alignment with Italian industrial priorities alongside commercial fundamentals. The firm is a strong fit for Italian deep tech and healthcare founders who benefit from a state-backed anchor investor with deep institutional reach. Founders looking for purely financial investors without policy considerations or those operating outside Italy will find better fits elsewhere in the European ecosystem.